Modifying Effects of Chemicals on the Development of Liver Preneoplastic Placental Glutathione S -Transferase Positive Foci in Analbuminemic and Sprague-Dawley Rats
Free accessResearch articleFirst published online June, 1993
Modifying Effects of Chemicals on the Development of Liver Preneoplastic Placental Glutathione S -Transferase Positive Foci in Analbuminemic and Sprague-Dawley Rats
Nagase analbuminemic rats (NARs) were compared to the Sprague-Dawley (SD) stock in a medium-term assay system for hepatocarcinogenesis regarding their susceptibilities to the influence of chemicals on the development of glutathione S-transferase, placental form, positive (GST-P+) foci. Two weeks after initiation with diethylnitrosamine (DEN), the animals were exposed alternatively to 0.06% 3'-methyl-4-dimethyl-aminoazobenzene(3'-Me-DAB), 50 ppm DEN, 0.25% ethionine, 1% clofibrate, and 1% butylated hydroxyanisole (BHA) for a 6-wk period. Adequate controls included groups only initiated with DEN or treated with each test compound alone. For evaluation of the modifying potential of the chemicals, indices were generated by using the mean values obtained for number and area of GST-P+ foci after each treatment. Comparison between these indices suggests that SD rats were relatively more sensitive than NARs to the modifying effects of complete carcinogens (3'-Me-DAB and DEN). The strains were similarly susceptible to the promoting influence of ethionine, a nongenotoxic carcinogen. The inhibitory influence of BHA was more intense in NARs, whereas in both strains clofibrate was associated to similarly reduced values for number and area of GST-P+ foci. The degree of susceptibility of each strain to the modifying influence of chemicals on foci development depended on the chemical agent investigated.
1. Asamoto M, Tsuda H, Kagawa M, de Camargo JLV, Ito N, and Nagase S (1989). Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of rat hepatocarcinogenesis in a medium-term assay system: Quantitation of glutathione S-transferase P-positive foci development. Jpn. J. Cancer Res. (Gann)80: 939–944.
2.
2. Asamoto M, Tsuda H, Kato T, Ito M, Masuko T, Hashimoto Y, and Nagase S (1989). Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of hepatocarcinogenesis: Immunohistochemical analysis of cytochrome P-450 isozyme induction by 2-acetylaminofluorene and phenobarbital. Jpn. J. Cancer Res. (Gann)80: 1041–1046.
3.
3. Bannasch P, Griesemer RA, Anders F, Becker R, Cabral JRP, et al (1986). Assays for initiating and promoting activities. In: Long-term and Short-term Assays for Carcinogens: A Critical Appraisal, R Montesano, H Bartasch, H Vainio, J Wilbourn, and H. Yamasaki (eds). IARC Scientific Publications No. 83. IARC, Lyon, pp. 103–126.
4.
4. Cohen SM and Ellwein LB (1991). Genetic errors, cell proliferation, and carcinogenesis. Cancer Res.51: 6493–6505.
5.
5. Dragan YP, Rizvi T, Xu -H, Hully JR, Bawa N, Campbell HA, Maronpot RR, and Pitot HC (1991). An initiation-promotion assay in rat liver as a potential complement to the 2-year carcinogenesis bio-assay. Fund. Appl. Toxicol.16: 525–547.
6.
6. Dyroff MC, Richardson FC, Popp JA, Bedell MA, and Swenberg JA (1986). Correlation of O4-ethylde-oxythymidine accumulation, hepatic initiation and hepatocellular carcinoma induction in rats continuously administered diethylnitrosamine. Carcinogenesis7: 241–246.
7.
7. Farber E and Rubin H (1991). Cellular adaptation in the origin and development of cancer. Cancer Res.51: 2751–2761.
8.
8. Glauert HP, Beer D, Sambasiva Rao M, Schwarz M, Xu Y-D, Goldsworthy TLM, Coloma J, and Pitot HC (1986). Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. Cancer Res.46: 4601–4606.
9.
9. Hosaka Y, Muramatsu M, Matsushima T, Niijima T, and Nagase S (1985). Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Jpn. J. Cancer Res. (Gann)76: 577–582.
10.
10. Hosokawa S, Tatematsu M, Aoki T, Nakanowatari J, Igarashi T, and Ito N (1989). Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator. Carcinogenesis10: 2237–2241.
11.
11. Imaida K, Tatematsu M, Kato T, Tsuda H, and Ito N (1989). Advantages and limitations of stereological estimation of placental glutathione S-transferase positive rat liver foci by computerized three-dimensional reconstruction. Jpn. J. Cancer Res. (Gann)80: 326–330.
12.
12. Ito N, Tatematsu M, Hasegawa R, and Tsuda H (1989). Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogens utilizing the GST-P positive liver cell focus as an endpoint marker. Toxicol. Pathol.17: 630–641.
13.
13. Ito N, Tsuda H, Tatematsu M, Inoue T, Tagahawa Y, Aoki T, Uwagawa S, Kagawa M, Ogiso T, Masui T, Imaida K, Fukushima S, and Asamoto M (1988). Enhancing effect of various hepatocarcinogenes on induction of preneoplastic glutathione S-transferase placental form positive foci in rats—An approach for a new medium-term bioassay system. Carcinogenesis9: 387–394.
14.
14. Kakizoe T, Komatsu H, Honma Y, Niijima T, Kawachi T, Sugimura T, and Nagase S (1982). High susceptibility of analbuminemic rats to induced bladder cancer. Br. J. Cancer45: 474–476.
15.
15. Kakizoe T and Sugimura T (1988). Chemical carcinogenesis in analbuminemic rats. Jpn. J. Cancer Res. (Gann)79: 775–784.
16.
16. Kanduc D, Goshala A, Quagliariello E, and Farber E (1988). DNA hypomethylation in ethionine-induced rat preneoplastic hepatocyte nodules. Biochem. Biophys. Res. Commun.150: 739–744.
17.
17. Leopold WR, Miller JA, and Miller EC (1982). Comparison of some carcinogenic, mutagenic, and biochemical properties of S-vinylhomocysteine and ethionine. Cancer Res.42: 4364–4374.
18.
18. Makino R, Sato S, Esumi R, Negishi C, Takano M, Sugimura T, Nagase S, and Tanaka H (1987). Presence of albumin-positive cells in the liver of analbuminemic rats and their increase on treatment with carcinogenesis. Jpn. J. Cancer Res. (Gann)77: 153–159.
19.
19. Miller JA (1970). Carcinogenesis by chemicals: An overview—G.H.A. Clowes Memorial Lecture. Cancer Res.30: 559–576.
20.
20. Moore CJ, Bachhuber AJ, and Gould MN (1983). Relationship of mammary tumor susceptibility, mammary cell-mediated mutagenesis, and metabolism of polycyclic aromatic hydrocarbons in four types of rats. J. Natl. Cancer Inst.70: 931–936.
21.
21. Nagase S, Shimamune K, and Shumiya S (1979). Albumin-deficient rat mutant. Science205: 590–591.
22.
22. Nagase S, Shumiya S, Emori T, and Tanaka H (1983). High incidence of renal tumors induced by N-dimethylnitrosamine in analbuminemic rats. Gann74: 317–318.
23.
23. Nagase S, Shumiya S, Emori T, and Tanaka H (1983). Induction of intestinal tumors in analbuminemic rats by azoxymethane.Proc. Jpn. Cancer Assoc., 42nd Annu. Meet., 50 (in Japanese).
24.
24. Nagase S, Shumiya S, Tanaka H, and Nagasawa H (1984). Mammary tumor induction in analbuminemic rats by 7,12-dimethylbenz(a)anthrance. Eur. J. Cancer Clin. Oncol.20: 283–286.
25.
25. Nakanowatari JI, Fukushima S, Imaida K, Ito N, and Nagase S (1988). Strain differences in N-butyl-N-(4-hydroxybutyl) nitrosamine bladder carcinogenesis in rats. Jpn. J. Cancer Res. (Gann)79: 453–459.
26.
26. Ogiso R, Tatematsu M, Tamano S, Hasegawa R, and Ito N (1990). Correlation between medium-term liver bioassay system data and results of long-term testing in rats. Carcinogenesis11: 561–566.
27.
27. Pitot HC, Campbell HA, Maronpot R, Bawa N, Rizvi TA, Xu Y-H, Sargent L, Dragan Y, and Pyron M (1989). Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Toxicol. Pathol.17: 594–612.
28.
28. Pitot HC, Goldsworthy TL, Moran S, Kennan W, Glauert HP, Maronpot R, and Campbell HA (1987). A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis8: 1491–1499.
29.
29. Rao MS, Nemali MR, Usuda N, Scarpelli G, Makino T, Pitot HC, and Reddy JK (1988). Lack of glutathione S-transferase P, glutamyl transpeptidase, and α-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Cancer Res.48: 4919–4925.
30.
30. Sato S, Makino R, Esumi H, Takahashi Y, Sugimura T, Nagase S, and Tanaka H (1980). Studies on carcinogenesis in analbuminemic rats.Proc. Jpn. Cancer Assoc., 39th Annu. Meet., 55 (in Japanese).
31.
31. Sugiyama K, Nagase S, Maekawa A, Onodera H, and Hayashi Y (1986). High susceptibility of analbuminemic rats to gastric tumor induction by N-methyl-N'-nitro-N-nitrosoguanidine. Jpn. J. Cancer Res. (Gann)77: 219–221.
32.
32. Takahashi M, Onodera H, Maekawa A, Hayashi Y, and Nagase S (1985). Carcinogenicity test of 3-methylcholanthrene in analbuminemic rat skin. Proc. Jpn. Cancer Assoc., 44th Annu. Meet., 80 (in Japanese).
33.
33. Takahashi M, Shumiya S, Maekawa A, Hayashi Y, and Nagase S (1988). High susceptibility of an analbuminemic congenic strain of rats with an F344 genetic background to induced bladder cancer and its possible mechanism. Jpn. J. Cancer Res. (Gann)79: 705–709.
34.
34. Tatematsu M, Aoki T, Kagawa M, Mera Y, and Ito N (1988). Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats. Carcinogenesis9: 221–225.
35.
35. Ward JM, Tsuda H, Tatematsu M, Hagiwara A, Ito N (1989). Hepatotoxicity of agents that enhance formation of foci hepatocellular proliferative lesions (putative preneoplastic foci) in a rapid rat liver bio-assay. Fund. Appl. Toxicol.12: 163–171.
